Pharma BD Deal Intelligence
Johnson & Johnson / Crucell NV
2003 · Acquisition/Merger · $2.4B · Complete
Announcement Sentiment
63
Positive
Outcome Score
75
Worked — the deal delivered on its rationale.
J&J acquired Crucell for $2.4B as a vaccine center, later called Janssen Vaccines.
Did it work? Outcome assessment
J&J / Crucell: Achieved Stated Rationale (Score: 75/100)
Strategic verdict
Achieved Stated Rationale
Assessment window: 5yr post-close.
Key facts
- Announced Jan 08, 2003
- Closed Feb 01, 2011
- Deal value $2.4B
- Deal type Acquisition/Merger
- Therapeutic area Infectious Disease, Vaccines
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals